BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 22983423)

  • 1. FGF23 production by osteocytes.
    Bonewald LF; Wacker MJ
    Pediatr Nephrol; 2013 Apr; 28(4):563-8. PubMed ID: 22983423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKD.
    Clinkenbeard EL; Noonan ML; Thomas JC; Ni P; Hum JM; Aref M; Swallow EA; Moe SM; Allen MR; White KE
    JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: the role of fibroblast growth factor 23.
    Sapir-Koren R; Livshits G
    Biofactors; 2014; 40(6):555-68. PubMed ID: 25352227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease.
    Wolf M; White KE
    Curr Opin Nephrol Hypertens; 2014 Jul; 23(4):411-9. PubMed ID: 24867675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo.
    Rhee Y; Bivi N; Farrow E; Lezcano V; Plotkin LI; White KE; Bellido T
    Bone; 2011 Oct; 49(4):636-43. PubMed ID: 21726676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [FGF23 and osteonetwork].
    Fukumoto S
    Clin Calcium; 2016 Aug; 26(8):1143-7. PubMed ID: 27461497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High calcium, phosphate and calcitriol supplementation leads to an osteocyte-like phenotype in calcified vessels and bone mineralisation defect in uremic rats.
    Bisson SK; Ung RV; Picard S; Valade D; Agharazii M; Larivière R; Mac-Way F
    J Bone Miner Metab; 2019 Mar; 37(2):212-223. PubMed ID: 29603070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway.
    Rowe PS
    Crit Rev Eukaryot Gene Expr; 2012; 22(1):61-86. PubMed ID: 22339660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D sterols increase FGF23 expression by stimulating osteoblast and osteocyte maturation in CKD bone.
    Pereira RC; Salusky IB; Bowen RE; Freymiller EG; Wesseling-Perry K
    Bone; 2019 Oct; 127():626-634. PubMed ID: 31377240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for FGF23 involvement in a bone-kidney axis regulating bone mineralization and systemic phosphate and vitamin D homeostasis.
    Martin A; Quarles LD
    Adv Exp Med Biol; 2012; 728():65-83. PubMed ID: 22396162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of klotho deletion from bone during chronic kidney disease.
    Kaludjerovic J; Komaba H; Lanske B
    Bone; 2017 Jul; 100():50-55. PubMed ID: 28232146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditional Deletion of Murine Fgf23: Interruption of the Normal Skeletal Responses to Phosphate Challenge and Rescue of Genetic Hypophosphatemia.
    Clinkenbeard EL; Cass TA; Ni P; Hum JM; Bellido T; Allen MR; White KE
    J Bone Miner Res; 2016 Jun; 31(6):1247-57. PubMed ID: 26792657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phosphate sensing and osteocyte].
    Michigami T
    Clin Calcium; 2012 Oct; 22(10):1551-6. PubMed ID: 23023636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronological immunolocalization of sclerostin and FGF23 in the mouse metaphyseal trabecular and cortical bone.
    Sakurai A; Hasegawa T; Kudo A; Shen Z; Nagai T; Abe M; Yoshida T; Hongo H; Yamamoto T; Yamamoto T; Oda K; Freitas PHL; Li M; Sano H; Amizuka N
    Biomed Res; 2017; 38(4):257-267. PubMed ID: 28794403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation regulates fibroblast growth factor 23 production.
    Francis C; David V
    Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):325-32. PubMed ID: 27191351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteocytic FGF23 and Its Kidney Function.
    Agoro R; Ni P; Noonan ML; White KE
    Front Endocrinol (Lausanne); 2020; 11():592. PubMed ID: 32982979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excessive Osteocytic Fgf23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice.
    Murali SK; Andrukhova O; Clinkenbeard EL; White KE; Erben RG
    PLoS Biol; 2016 Apr; 14(4):e1002427. PubMed ID: 27035636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The osteocyte in CKD: new concepts regarding the role of FGF23 in mineral metabolism and systemic complications.
    Wesseling-Perry K; Jüppner H
    Bone; 2013 Jun; 54(2):222-9. PubMed ID: 23079136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Aspects of the Kidney in the Regulation of Fibroblast Growth Factor 23 (FGF23) and Mineral Homeostasis.
    Mace ML; Olgaard K; Lewin E
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth-related skeletal changes and alterations in phosphate metabolism.
    Michigami T; Tachikawa K; Yamazaki M; Nakanishi T; Kawai M; Ozono K
    Bone; 2022 Aug; 161():116430. PubMed ID: 35577326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.